Trials / Completed
CompletedNCT02541760
Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Hormozgan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Monteleukast | 4 ml monteleukast daily for one month |
| DRUG | Mometasone | Inhaled mometasone 1 puff in each side of nose for one month |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-03-01
- Completion
- 2015-04-01
- First posted
- 2015-09-04
- Last updated
- 2015-09-04
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02541760. Inclusion in this directory is not an endorsement.